• SGX entered a new licensing agreement with MSCI to expand its equity derivatives lineup, with up to 100 new futures and options contracts planned.
• Initial rollout targets about 40 contracts spanning developed and emerging market benchmarks, aiming to broaden SGX’s global equity risk-hedging offering.
• Deal deepens a long-running SGX-MSCI partnership, positioning SGX as an offshore venue for centrally cleared benchmark exposure and portfolio hedging.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SGX - Singapore Exchange Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: NG43XRWWQ4N6E7JT) on July 23, 2026, and is solely responsible for the information contained therein.